Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|April 4, 2022
Fruquintinib Enhances the Antitumor Immune Responses of Anti-Programmed Death Receptor-1 in Colorectal CancerQingli Li, Xiaojiao Cheng, Cong Zhou, et al.
Oncoimmunology|October 21, 2022
Targeting depletion of myeloid-derived suppressor cells potentiates PD-L1 blockade efficacy in gastric and colon cancersYao Tang, Cong Zhou, Qingli Li, et al.
Scientific Reports|January 29, 2024
A pancancer analysis of the clinical and genomic characteristics of multiple primary cancersBaiwen Zhang, Lina He, Cong Zhou, et al.
Journal of Gastrointestinal Oncology|January 10, 2024
Significant response from fruquintinib plus anti-PD-1 immunotherapy for microsatellite stable metastatic colorectal cancer with liver and lung metastasis in the third line: case reportLina He, Xiaojiao Cheng, Cong Zhou, et al.
Cell Death & Disease|April 2, 2021
Utidelone inhibits growth of colorectal cancer cells through ROS/JNK signaling pathwayFuli Li, Tinglei Huang, Yao Tang, et al.
Nutrition and Cancer|December 2, 2014
NNK-induced DNA methyltransferase 1 in lung tumorigenesis in A/J mice and inhibitory effects of (-)-epigallocatechin-3-gallateHuanyu Jin, Jayson X Chen, Hong Wang, et al.
Frontiers in Immunology|April 1, 2021
Wnt Inhibition Sensitizes PD-L1 Blockade Therapy by Overcoming Bone Marrow-Derived Myofibroblasts-Mediated Immune Resistance in TumorsTinglei Huang, Fuli Li, Xiaojiao Cheng, et al.
Frontiers in Oncology|July 5, 2021
A PD-1 Inhibitor Induces Complete Response of Advanced Bladder Urothelial Carcinoma: A Case ReportJianzheng Wang, Qingli Li, Huifang Lv, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 3, 2007
Gastrin regulates the TFF2 promoter through gastrin-responsive cis-acting elements and multiple signaling pathwaysShuiping Tu, Alfred L Chi, Seonhee Lim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
Comprehensive analysis of HLA-DR- and HLA-DP4-restricted CD4+ T cell response specific for the tumor-shared antigen survivin in healthy donors and cancer patientsXiao-Fei Wang, Jerome Kerzerho, Olivier Adotevi, et al.
Pageof 4